Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2014
03/19/2014CN102123712B Methods of cancer treatment with IGF1R inhibitors
03/19/2014CN101918544B Method for increasing immunoreactivity
03/19/2014CN101883582B Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
03/19/2014CN101743473B Method for detection or treatment of graft versus host disease
03/19/2014CN101524532B Single dose of a mycoplasma hyopneumoniae vaccine
03/19/2014CN101395174B Hpv antigens, vaccine compositions, and related methods
03/19/2014CN101198698B Process for production of polypeptide by regulation of assembly
03/18/2014US8674078 Methods of using BTL-II proteins
03/18/2014US8674077 Processes for producing silk dope
03/18/2014US8673870 Combined DNA vaccine and biological modifiers for cancer therapy
03/18/2014US8673629 Recombinant Rift Valley fever (RVF) viruses and methods of use
03/18/2014US8673612 Synthetic viruses and uses thereof
03/18/2014US8673552 Druggable regions in the dengue virus envelope glycoprotein and methods of using the same
03/18/2014US8673551 Methods, plasmid vectors and primers for assessing HIV viral fitness
03/18/2014US8673550 MSP nanopores and related methods
03/18/2014US8673361 Cytokine modulating composition
03/18/2014US8673321 Cyclophosphamide in combination with anti-idiotypic vaccines
03/18/2014US8673320 Metal-citrate transporter antigen from Streptomyces coelicolor and uses thereof
03/18/2014US8673319 Chimpanzee adenovirus vaccine carriers
03/18/2014US8673318 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
03/18/2014US8673317 Codon-optimized polynucleotide-based vaccines against human Cytomegalovirus infection
03/18/2014US8673316 Avirulent, immunogenic flavivirus chimeras
03/18/2014US8673315 Method for producing vaccinal viral strain of a virus of the reoviridae family
03/18/2014US8673314 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
03/18/2014US8673313 Cell penetrating peptides and its use fused to biomolecules with therapeutic action
03/18/2014US8673312 Method for one-step purification of recombinant Helicobacter pylori neutrophil-activating protein
03/18/2014US8673311 Bacterial spore having therapeutic agent adsorbed on its surface
03/18/2014US8673310 Stable and soluble antibodies inhibiting TNFα
03/18/2014US8673309 Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
03/18/2014US8673308 Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases
03/18/2014US8673307 HIV-1 anti-core neutralizing antibodies that target a conformational epitope within the ALPHA5-helix of GP120
03/18/2014US8673306 Compositions and methods of use for antibodies of dickkopf-1
03/18/2014US8673305 Methods of treatment with antibodies against the extracellular loops of C5aR
03/18/2014US8673304 Humanized anti-CD4 antibody with immunosuppressive properties
03/18/2014US8673303 Cripto blocking antibodies and uses thereof
03/18/2014US8673301 YKL-40 monoclonal antibody
03/18/2014US8673300 Therapeutic compositions and methods for the prevention of autoimmune diseases
03/18/2014US8673299 Anti-RANTES antibodies
03/18/2014US8673298 Stabilized compositions of proteins having a free thiol moeity
03/18/2014US8673296 Method and composition for producing a cellular allogeneic vaccine
03/18/2014US8673293 Use of modified cells for the treatment of multiple sclerosis
03/18/2014US8673289 Attenuated uracil auxotroph of an apicomplexan and use thereof
03/18/2014US8673285 Sphingoid polyalkylamine conjugates for vaccination
03/18/2014CA2703263C Immunosuppressive polypeptides and nucleic acids
03/18/2014CA2680945C Anti-pdgfralpha antibodies
03/18/2014CA2578147C Modified hiv-1 envelope proteins
03/18/2014CA2569788C Tumor specific antibody
03/18/2014CA2567808C Therapy of platinum-resistant cancer
03/18/2014CA2564512C Artificial immune system: methods for making and use
03/18/2014CA2530364C Vaccines against group y neisseria meningitidis and meningococcal combinations thereof
03/18/2014CA2520671C Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
03/18/2014CA2496834C Method of treatment of asthma using antibodies to complement component c5
03/18/2014CA2480682C Nucleic acid sequence and protein, and polypeptides encoding mannitol dehydrogenases or parts thereof, and their preparation and use in diagnostics and therapy
03/18/2014CA2355364C Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
03/17/2014CA2789885A1 Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor
03/13/2014WO2014040089A1 Tumor lysate loaded particles
03/13/2014WO2014040040A1 Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus ( derzsy's disease)
03/13/2014WO2014040025A2 Immunogens of hiv-1 broadly neutralizing antibodies, methods of generation and uses thereof
03/13/2014WO2014040024A1 The use of antibodies in treating hiv infection and suppressing hiv transmission
03/13/2014WO2014039983A1 Vista modulators for diagnosis and treatment of cancer
03/13/2014WO2014039978A2 Vaccine to prevent mycoplasmal infection in waterfowl
03/13/2014WO2014039975A2 Anti-mcam antibodies and associated methods of use
03/13/2014WO2014039958A1 Immune function biomarkers
03/13/2014WO2014039903A2 Stable aqueous formulations of adalimumab
03/13/2014WO2014039855A1 Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor
03/13/2014WO2014039840A1 Hiv vaccine compositions and methods
03/13/2014WO2014039775A1 Hiv-1 antigens with discrete conformational forms of the v1/v2 domain and methods of use thereof
03/13/2014WO2014039746A1 Hiv immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto
03/13/2014WO2014039682A1 Antibody formulations and uses thereof
03/13/2014WO2014039675A2 Target peptides for colorectal cancer therapy and diagnostics
03/13/2014WO2014039021A1 Cchfv vaccine
03/13/2014WO2014039012A1 Hyaluronic acid-based drug delivery systems
03/13/2014WO2014038662A1 Dna vaccine against pseudotuberculosis in marine fish
03/13/2014WO2014037899A2 Il-18 binding molecules
03/13/2014WO2014037717A1 Compositions and methods relating to the treatment of diseases
03/13/2014WO2014037680A1 High concentration aqueous protein solution having reduced viscosity
03/13/2014WO2014037592A1 Recombinant protein ofhaemonchus contortus and use thereof for the production of a vaccine against haemonchosis
03/13/2014WO2014037585A1 Bioconjugates comprising modified antigens and uses thereof
03/13/2014WO2014037472A1 Combination vaccines with serogroup b meningococcus and d/t/p
03/13/2014WO2014037445A1 Preparation of live vaccines
03/13/2014WO2014037440A2 A novel live attenuated shigella vaccine
03/13/2014WO2014037409A1 Vsv-hiv viral particles lacking reverse transcriptase functionality and therapeutic applications thereof
03/13/2014WO2014037367A1 An immunogenic composition comprising an inactivated recombinant non-pathogenic bacterium
03/13/2014WO2014037316A1 Combination treatment of cancer
03/13/2014WO2014037124A1 Methods and compositions for enhancing vaccine immune responses
03/13/2014WO2014037103A1 Live attenuated metabolic drift vaccine against fowl typhoid
03/13/2014WO2014036847A1 Fusion protein of human cytomegalovirus immunogen as well as preparation method therefor and use thereof
03/13/2014WO2014036807A1 Recombinant herpes simplex virus, preparation method therefor and application thereof
03/13/2014WO2014036735A1 Use of duck enteritis viral vaccine strain as expression vector for preparing recombinant viral vaccine for preventing galliformes avian diseases
03/13/2014WO2014036608A1 Methods and products for preventing and/or treating metastatic cancer
03/13/2014WO2014015137A3 Compositions and methods for treating dysproliferative diseases
03/13/2014WO2014014897A3 Immunoglobulin-binding human mycoplasma antigens and methods of use thereof
03/13/2014WO2014011489A3 Monoclonal antibodies for use in diagnosis and therapy of cancers and automimmune disease
03/13/2014WO2014011274A3 Metalloproteinase-9 oligopeptides and their therapeutic use
03/13/2014WO2013181634A3 Antigen binding proteins that bind pd-l1
03/13/2014WO2013181571A3 Methods related to trastuzumab
03/13/2014WO2013166453A3 T cell epitopes from cockroach and methods of making and using same
03/13/2014WO2013164754A3 Prostate-associated antigens and vaccine-based immunotherapy regimens
03/13/2014WO2013164689A3 Humanized pan-her antibody compositions
03/13/2014WO2013158821A3 Methods of treating ankylosing spondylitis using il-17 antagonists
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 1823